Cargando…
Acute and Subchronic Toxicological Evaluation of the Herbal Product HAD-B1 in Rats
This study evaluates acute and subchronic toxicity of a Korean herbal formula HAD-B1 in rat to investigate whether HAD-B1 has potential toxicity to humans. First, the study to assess the acute oral toxicity at dose levels of 0, 500, 1000, and 2000 mg/kg body weight (BW) was performed in male and fem...
Autores principales: | Park, So-Jung, Kim, Soo-Dam, Kwag, Eun-Bin, Park, Ji Hye, Yoo, Hwa-Seung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184334/ https://www.ncbi.nlm.nih.gov/pubmed/34194531 http://dx.doi.org/10.1155/2021/9970822 |
Ejemplares similares
-
Acute and sub-chronic toxicological evaluation of the herbal product HAD-B1 in Beagle dogs
por: Song, Si-Yeon, et al.
Publicado: (2021) -
Nonclinical Safety Pharmacology Study of the Herbal Product HAD-B1
por: Kim, Soo-Dam, et al.
Publicado: (2021) -
The Current Status of Integrative Oncology in Korea
por: Kwag, Eun-Bin, et al.
Publicado: (2021) -
Multi-Center, Randomized, Double-Blind, Placebo-Controlled,
Exploratory Study to Evaluate the Efficacy and Safety of HAD-B1 for Dose-Finding
in EGFR Mutation Positive and Locally Advanced or Metastatic NSCLC Subjects Who
Need Afatinib Therapy
por: Ko, Eun-Ju, et al.
Publicado: (2021) -
Synergistic Effect of HAD-B1 and Afatinib Against Gefitinib
Resistance of Non-Small Cell Lung Cancer
por: Song, Si Yeon, et al.
Publicado: (2022)